Funding Opportunities and Deadlines

Research Priority

Immunotherapies

Letter of Intent Due

September 12

Innovative Strategies To Demonstrate “Immunological Proof-of-Mechanism” And To Explore Early Outcome Measures In Immunotherapy Trials

Details

Milestone Date Status
Letter of Intent Sep 12, 2018 Next
Application Nov 14, 2018
Award Notification May 31, 2019
Earliest Start Jul 01, 2019
Immunotherapies

Letter of Intent Due

October 08

Therapeutic Development and Early Clinical Testing of T Cell Targeted Immunotherapies for the Treatment of Type 1 Diabetes

Details

Milestone Date Status
Letter of Intent Oct 08, 2018 Next
Application Jan 07, 2019
Award Notification Jul 31, 2019
Earliest Start Sep 01, 2019

Ongoing Opportunities

These funding sources are typically available annually or ongoing

Conference Grants

Industry Discovery & Development Partnerships

Project Concepts (Strategic Research Agreement)
Nov 01

Early-Career Patient-Oriented Diabetes Research Awards (projects in COMPLICATIONS are ineligible)
Jan 31

Career Development Awards (projects in COMPLICATIONS are ineligible)
Jan 31

Advanced Postdoctoral Fellowships (projects in COMPLICATIONS are ineligible)
Jan 31

Postdoctoral Fellowships (projects in COMPLICATIONS are ineligible)
Jan 31

RFAs Awaiting Notification

Sep

JDRF Canadian Clinical Trial Network (CCTN) FY18 Postdoctoral Fellowship in Clinical Translation in T1D Program
Oct

Restoring Pancreatic Alpha Cell Function to Improve Metabolic Control in Type 1 Diabetes